Pravastatin Protects Against Avascular Necrosis of Femoral Head via Autophagy.
Pravastatin Protects Against Avascular Necrosis of Femoral Head via Autophagy.
复制标题
DOI：
10.3389/fphys.2018.00307
复制
发表时间：
2018
影响因子：
4
通讯作者：
Bao S
中科院分区：
文献类型：
--
作者：
Liao Y;Zhang P;Yuan B;Li L;Bao S
Autophagy serves as a stress response and may contribute to the pathogenesis of avascular necrosis of the femoral head induced by steroids. Statins promote angiogenesis and ameliorate endothelial functions through apoptosis inhibition and necrosis of endothelial progenitor cells, however the process used by statins to modulate autophagy in avascular necrosis of the femoral head remains unclear. This manuscript determines whether pravastatin protects against dexamethasone-induced avascular necrosis of the femoral head by activating endothelial progenitor cell autophagy. Pravastatin was observed to enhance the autophagy activity in endothelial progenitor cells, specifically by upregulating LC3-II/Beclin-1 (autophagy related proteins), and autophagosome formation in vivo and in vitro. An autophagy inhibitor, 3-MA, reduced pravastatin protection in endothelial progenitor cells exposed to dexamethasone by attenuating pravastatin-induced autophagy. Adenosine monophosphate-activated protein kinase (AMPK) is a key autophagy regulator by sensing cellular energy changes, and indirectly suppressing activation of the mammalian target of rapamycin (mTOR). We found that phosphorylation of AMPK was upregulated however phosphorylation of mTOR was downregulated in pravastatin-treated endothelial progenitor cells, which was attenuated by AMPK inhibitor compound C. Furthermore, liver kinase B1 (a phosphorylase of AMPK) knockdown eliminated pravastatin regulated autophagy protein LC3-II in endothelial progenitor cells in vitro. We therefore demonstrated pravastatin rescued endothelial progenitor cells from dexamethasone-induced autophagy dysfunction through the AMPK-mTOR signaling pathway in a liver kinase B1-dependent manner. Our results provide useful information for the development of novel therapeutics for management of glucocorticoids-induced avascular necrosis of the femoral head.
登录
查看更多内容
影响因子：
56.9
作者：
Asahara, T;Murohara, T;Isner, JM
通讯作者：
Isner, JM
影响因子：
14
作者：
Liu, Hongjuan;Wise, Steven G.;Bao, Shisan
通讯作者：
Bao, Shisan
影响因子：
5
作者：
Araki, Makoto;Maeda, Masatomo;Motojima, Kiyoto
通讯作者：
Motojima, Kiyoto
影响因子：
3.7
作者：
Jiang W;Wei W;Gaertig MA;Li S;Li XJ
通讯作者：
Li XJ
影响因子：
--
作者：
Ahn JS;Ann EJ;Kim MY;Yoon JH;Lee HJ;Jo EH;Lee K;Lee JS;Park HS
通讯作者：
Park HS